Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/07/055723
CTRI/2023/07/055723
Not Yet Recruiting
Phase 4

A Clinical Study to Evaluate the Safety and Efficacy of Panchakarma Essential in male patients with generalized anxiety disorder - NI

Mprex Healthcare Pvt. Ltd.0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Mprex Healthcare Pvt. Ltd.
Status
Not Yet Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.Male subjects 30\-60 years of age will be included.2\.Male Subjects with no history of allergy to oils.3\.Be willing to refrain from taking any medication during or before the study for the said indication.4\.An ambulatory subject can provide verbal and written consent and is ready to comply with all study procedures.

Exclusion Criteria

  • •1\. Male Subjects with Depression, Social phobias, Hypertension, Cardiac diseases, Epilepsy, Asthma, Hyperthyroidism, Alcoholics, and Drug addicts
  • •2\. History of psychiatric disorder that may impair the ability of subjects to provide written informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
Phase 2
Effect of Decoction of Cuscuta Reflexa and local application of Saussurea Lappa and Honey in the management of Melasma.
CTRI/2021/03/032083Central Council of Research in Unani Medicine New Delhi
Not Yet Recruiting
Phase 4
To study the effect of Panchakarma Essential in female patients with anxiety.
CTRI/2023/08/056234Mprex Healthcare Pvt. Ltd.
Not Yet Recruiting
Phase 4
To evaluate the Safety and Efficacy of ACELABS Serum
CTRI/2024/02/063322Bright Diva Pte. Ltd.
Not Yet Recruiting
N/A
To study the effect of Panchakarma Essential in reducing symptoms with cardiopulmonarydisordersHealth Condition 1: I249- Acute ischemic heart disease, unspecified
CTRI/2023/11/060197Mprex Healthcare Pvt.Ltd. Wakad, pune
Completed
Phase 2
TO Find the Effect of LION�S MANE CAPSULE as Nutritional SupplementHealth Condition 1: E089- Diabetes mellitus due to underlying condition without complications
CTRI/2022/03/040725DXN Manufacturing India Pvt Ltd24